The most frequently occurring lung cancer type is non-small-cell cancer (NSCLC). Over the past three decades, the median survival time of advanced NSCLC has increased from approximately six months in the 1980's to nine months twenty years later; mortality rates are still very high. This article looks at recent studies which have given a strong positive signal that complementary/supportive TCM-herbal treatment next to conventional platinum-based chemotherapy improves prognosis in advanced NSCLC patients. Several of the TCM herbs used have an immune-stimulating effect, of particular interest for nivolumab-treated patients. Additional research needed to obtain definitive clinical evidence for the prognosis-improving effect of TCM treatment in conjunction with platinum-based chemotherapy is also discussed, and recommendations made for supportive clinical management of NSCLC with complementary TCM at the present time, until such data is available. Read the whole article.